Skip to main content
Signal8

ENvue Medical, Inc. (FEED) Form 10-Q — May 18, 2026

$FEEDForm 10-QFiled May 18, 2026, 4:36 PM ET0001493152-26-024191Original filing

ENvue Medical reported a net loss of $3.8 million for the first quarter of 2026, driven by a 36% decline in revenue to $653,000 and significant operating expenses. The company explicitly stated that these conditions raise substantial doubt about its ability to continue as a going concern for the next twelve months, citing insufficient cash reserves to fund operations without additional financing. The financial results were heavily impacted by non-cash charges, including a $17 million deemed dividend resulting from down-round adjustments to its Series H Preferred Stock conversion price.

Key figures

Revenue
653000
Total Debt
1080000
Total Assets
39871000
Cash Position
2235000
Warrant liability
824000
Shares outstanding
6091840
Arbitration liability
2285000

Price after filing

1 day: -5.0%7 days: -7.9%30 days: -23.7%

Close on the filing date to close N calendar days later (from $1.01). Historical, not a forecast.

AI analysis

Red flags7 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.